AltStreet
EDGAR Verified
Primary Source · SEC.gov

Cultivation Capital Life Sciences Fund IV, LP

Fund Vehicle2026 vintage506(b), 3(c)(1)
Latest signalFirst saleForm D/A · 2026-03-263 events: 1 first sale, 1 sold increased, 1 new form d filerLast filing 2026-03-26

Raised

$7M

Investors

—

Min Invest

$250,000

AltStreet Analysis

·

Generated from EDGAR primary sources

Cultivation Capital Life Sciences Fund IV, LP is a Delaware-organized pooled investment fund targeting longevity and biotechnology investments. This amended Form D reports $6.5M raised under Rule 506(b) and 3(c)(1) exemptions, with a $250K minimum investment. The fund is managed by LLC Life Sciences Fund IV GP, with seven directors including William Schmidt, Sean Morris, Catherine Matthes, Joel Crater, Scott Addonizio, and David Narrow.

This life sciences-focused venture fund employs a standard 506(b) private placement structure common in institutional biotech investing. The $250K minimum positions it at the lower end of institutional fund access thresholds, potentially accommodating qualified clients alongside high-net-worth individuals. The 3(c)(1) exemption suggests a sub-100 investor cap typical of venture capital limited partnerships.

Data Flags

generalAmendment filing with relatively modest $6.5M total raise for a Fund IV vehicle, suggesting either early-stage closing or a smaller successor fund than typical sequential fundraising patterns
total_investorsInvestor count not disclosed on amended filing despite capital already raised, limiting transparency into investor concentration

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0002044678
Entity NameCultivation Capital Life Sciences Fund IV, LP
ExemptionRule 506(b), Section 3(c), Section 3(c)(1)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising. Section 3(c) of the Investment Company Act of 1940: the issuer is a pooled investment vehicle relying on an exclusion from registration as an investment company. Section 3(c)(1) of the Investment Company Act: the fund is excluded from investment-company registration because it has no more than 100 beneficial owners.
Entity TypeLimited Partnership
Jurisdiction of OrganizationDelaware
Issuer Address1100 Corporate Square Drive, Suite 227, St. Louis, MO 63132
Phone(314) 216-2051
Industry / Fund TypePooled Investment Fund · Venture Capital Fund
Investment Company ActExcluded under Section 3(c)(1) (100 beneficial owners or fewer)
Securities TypePooled Investment Fund
First Sale Date—
Filing DateMarch 26, 2026
Accession Number0002044678-26-000001
Total Offering Amount$40,000,000
Total Amount Sold$6,500,000
Amount Remaining$33,500,000
Total Investors—
Non-Accredited InvestorsNone
Minimum Investment$250,000
Offering DurationOne year or less
Sales Commissions$0
Finders' Fees$0
Revenue RangeNot Applicable
State (Issuer Address)MO
Amendment Count1 amendments filed

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

D/AMarch 26, 2026DApril 2, 2025

Capital Raise Timeline

2 Form D filings from Apr 2, 2025 to Mar 26, 2026, the latest a D/A.

Checking access…

Fund Family

Every vehicle in this manager's series as it appears on EDGAR, newest generation first. Sold-to-date and investor counts are each vehicle's latest Form D.

Fund family

Cultivation Capital Life Sciences Fund2 vehicles · 2 generations · since 2016 · $25.7M sold across the family

This issuer is in Fund IV · Fund II has sold $19.2M to date across its vehicles

VehicleRoleFirst filedStatusSoldInvestors
Fund IV · first filed 2025-04-02 · 1 vehicle · $6.5M sold
Cultivation Capital Life Sciences Fund IV, LPthis issuer2025-04-02raising$6.5M0
Fund II · first filed 2016-11-01 · 1 vehicle · $19.2M sold · 54 investors
Cultivation Capital Life Sciences Fund II, LLC2016-11-01dark$19.2M54

Grouped from Form D issuer names (generation, sleeve, jurisdiction and legal-form tokens removed); a name-only match, so abbreviated or renamed vehicles can be missed. Sold and investor figures are each vehicle's latest Form D; sleeves that report the same figure share one family-wide total and are counted once. Performance lines are what a public pension plan reports for its own interest in that fund, net, on the plan's cash flows and valuation date; they are not the general partner's figures.

In the Terminal

Filing events

3

latest Mar 26, 2026

Critical / warning

0 / 0

0 watch · 3 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

raising

Latest event First sale · Mar 26, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 3 filing events with values and deltas, latest 2026-03-26, and alerts on the next one
  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Regulatory Activity

Filing events on this entity detected by AltStreet's EDGAR monitoring.

Mar 2026Form D amendment
SEC.gov

Signal analysis reserved for subscribers

Severity grading, value-change deltas, and analyst notes on these filings ship in the AltStreet newsletter and the Pro terminal.

Get the signal feed

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Cultivation Capital LLC

Promoter · Saint Louis, MO

Life Sciences Fund IV GP LLC

Director · Saint Louis, MO

William Schmidt

Director, Promoter · Saint Louis, MO

Sean Morris

Director, Promoter · Saint Louis, MO

Catherine Matthes

Director, Promoter · Saint Louis, MO

Joel Crater

Director, Promoter · Saint Louis, MO

Scott Addonizio

Director, Promoter · Saint Louis, MO

David Narrow

Director, Promoter · Saint Louis, MO

Questions About Cultivation Capital Life Sciences Fund IV, LP

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Cultivation Capital Life Sciences Fund IV, LP?

Cultivation Capital Life Sciences Fund IV, LP is a Delaware limited partnership that filed a Form D with the SEC on March 26, 2026 as a venture capital fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of pooled investment fund interests. AltStreet links the issuer to Cultivation Capital Life Sciences Fund IV, LP.

Is Cultivation Capital Life Sciences Fund IV, LP legit?

AltStreet does not rate legitimacy; it reports the public record. Cultivation Capital Life Sciences Fund IV, LP filed a Form D with the SEC on March 26, 2026 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $6,500,000 sold. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. The issuer is linked to Cultivation Capital Life Sciences Fund IV, LP, which AltStreet has reviewed. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Cultivation Capital Life Sciences Fund IV, LP registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Cultivation Capital Life Sciences Fund IV, LP claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Cultivation Capital Life Sciences Fund IV, LP raised?

Cultivation Capital Life Sciences Fund IV, LP reported $6,500,000 sold of a $40,000,000 total offering as of the Form D filed March 26, 2026.

Who can invest in Cultivation Capital Life Sciences Fund IV, LP?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000.

What is the minimum investment in Cultivation Capital Life Sciences Fund IV, LP?

The Form D lists $250,000 as the minimum investment accepted from any outside investor as of March 26, 2026. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling Cultivation Capital Life Sciences Fund IV, LP and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind Cultivation Capital Life Sciences Fund IV, LP?

The Form D lists 8 related persons: Cultivation Capital LLC, promoter (The Issuer's management company); Life Sciences Fund IV GP LLC, director (The Issuer's general partner); William Schmidt, director, promoter (Managing director of the Issuer); Sean Morris, director, promoter (Managing director of the Issuer); Catherine Matthes, director, promoter (Managing director of the Issuer); Joel Crater, director, promoter (Managing director of the Issuer); Scott Addonizio, director, promoter (Managing director of the Issuer); David Narrow, director, promoter (Managing director of the Issuer). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Cultivation Capital Life Sciences Fund IV, LP located?

The issuer's address on its SEC filings is 1100 Corporate Square Drive, Suite 227, St. Louis, MO 63132. Its phone number of record is 3142162051. It is organized under the laws of Delaware.

How long is the Cultivation Capital Life Sciences Fund IV, LP offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.

How large is Cultivation Capital Life Sciences Fund IV, LP?

The Form D reports a revenue range of Not Applicable.

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Claim Profile — FreeGet Verified — $2,400/yr

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.